NET PROFIT (x1000 DKK)
EMPLOYEES
Wilson Therapeutics AB
Closing information (x1000 DKK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover | 0 | 0 | 0 |
Financial expenses | 652,940 | 1,621 | 2,449 |
Earnings before taxes | -502,280 | 4,824,694 | -284,254 |
EBITDA | -620 | 4,766,830 | -292,216 |
Total assets | 4,774,272 | 9,316,264 | 58,671 |
Current assets | 4,774,197 | 9,315,213 | 10,398 |
Current liabilities | 49,699 | 4,267,363 | 32,456 |
Equity capital | 4,724,572 | 5,048,901 | 26,118 |
- share capital | 2,330 | 2,251 | 2,285 |
Employees (average) | 0 | 1 | 14 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency | 99.0% | 54.2% | 44.5% |
Turnover per employee | 0 | 0 | |
Profit as a percentage of turnover | |||
Return on assets (ROA) | 3.2% | 51.8% | -480.3% |
Current ratio | 9606.2% | 218.3% | 32.0% |
Return on equity (ROE) | -10.6% | 95.6% | -1088.3% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | -1 | -13 | 0 |
Chg. No. of employees % | -100% | -93% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.